Abivax (ABVX) Short term Debt (2021 - 2025)
Historic Short term Debt for Abivax (ABVX) over the last 5 years, with Q3 2025 value amounting to $32.8 million.
- Abivax's Short term Debt changed N/A to $32.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.8 million, marking a year-over-year change of. This contributed to the annual value of $13.9 million for FY2024, which is 6555.37% down from last year.
- Abivax's Short term Debt amounted to $32.8 million in Q3 2025.
- In the past 5 years, Abivax's Short term Debt registered a high of $40.2 million during Q4 2023, and its lowest value of $2.7 million during Q2 2024.
- In the last 5 years, Abivax's Short term Debt had a median value of $15.4 million in 2025 and averaged $20.9 million.
- Per our database at Business Quant, Abivax's Short term Debt plummeted by 6536.87% in 2024 and then skyrocketed by 49910.74% in 2025.
- Abivax's Short term Debt (Quarter) stood at $13.0 million in 2021, then skyrocketed by 163.78% to $34.2 million in 2022, then grew by 17.38% to $40.2 million in 2023, then tumbled by 65.37% to $13.9 million in 2024, then skyrocketed by 136.05% to $32.8 million in 2025.
- Its Short term Debt was $32.8 million in Q3 2025, compared to $16.0 million in Q2 2025 and $14.7 million in Q1 2025.